French body against xenotransplantation trials:
This article was originally published in Clinica
France should not yet permit human xenotransplantation trials, an official ethics body has declared. The National Consultative Ethics Committee for Health and Life Sciences said clinical trials should be delayed until research has clarified the risks of endoviruses crossing between species, according to a report in Nature (15 July).
You may also be interested in...
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from India's Glenmark.
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.
The French major and Regeneron have racked up another indication for Dupixent with the blockbuster getting approval in Europe to treat children with severe eczema.